Oppenheimer Asset Management Inc. Has $32.34 Million Holdings in Danaher Corporation $DHR

Oppenheimer Asset Management Inc. boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 2.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 163,134 shares of the conglomerate’s stock after purchasing an additional 4,350 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Danaher were worth $32,343,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in DHR. Sivia Capital Partners LLC grew its position in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after acquiring an additional 119 shares during the last quarter. Fifth Third Wealth Advisors LLC boosted its stake in Danaher by 4.6% in the second quarter. Fifth Third Wealth Advisors LLC now owns 6,502 shares of the conglomerate’s stock worth $1,284,000 after purchasing an additional 283 shares in the last quarter. GFS Advisors LLC bought a new stake in shares of Danaher during the second quarter worth $641,000. Sivik Global Healthcare LLC increased its stake in shares of Danaher by 14.3% in the second quarter. Sivik Global Healthcare LLC now owns 40,000 shares of the conglomerate’s stock valued at $7,902,000 after buying an additional 5,000 shares in the last quarter. Finally, Concurrent Investment Advisors LLC raised its holdings in shares of Danaher by 14.0% in the second quarter. Concurrent Investment Advisors LLC now owns 11,459 shares of the conglomerate’s stock valued at $2,264,000 after buying an additional 1,411 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the sale, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 11.20% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. JPMorgan Chase & Co. boosted their target price on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Guggenheim raised their price target on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Argus set a $265.00 price objective on Danaher in a report on Wednesday, January 14th. Finally, The Goldman Sachs Group reduced their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $253.86.

Danaher Stock Up 0.5%

Shares of Danaher stock opened at $216.77 on Monday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The business’s 50 day simple moving average is $229.62 and its 200 day simple moving average is $215.17. The firm has a market cap of $153.12 billion, a PE ratio of 43.01, a P/E/G ratio of 2.93 and a beta of 0.91.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.14 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is currently 25.40%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.